The American Academy of Pediatrics released its updated recommendations for vaccines on Tuesday, including Covid-19 shots for ...

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...

The American Academy of Pediatrics had earlier urged parents to get young children vaccinated against Covid — pushing back ...

The American Academy of Pediatrics released its vaccine schedule on Aug 19, which differs from the guidance provided by ...

Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.

Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...

People with weakened immune systems who received the Pfizer or Moderna vaccines can also get their third dose of a COVID-19 vaccine if it's been at least four weeks since the second dose (and if ...

Pfizer also said it is working to improve its existing vaccine formulation, developed jointly with Germany's BioNTech, based on the vaccine's reaction to new COVID-19 variants that arise.

London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.

Pfizer’s clinical trials in children 5 to 11 did not measure the vaccine’s effectiveness against COVID-19. Effectiveness was “never the intended primary endpoint,” Anderson said.

A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated photograph.